Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06274411 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

Study acronym: ECMO-READY
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints revised (9)v7
  2. Secondary endpoints: 7 to 9
    • Collaborators: 10 to 7
    • Study description expanded, about 5 words
    v6
  3. Start date changed from estimate of Dec 1, 2024 to Mar 21, 2025v5
  4. Primary completion date: Dec 31, 2025 to Nov 1, 2026
    • Study completion date: Mar 1, 2026 to Dec 1, 2026
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Start date: Mar 1, 2024 to Dec 1, 2024v2 Show 4 more changesShow less
    • Primary endpoint revised
    • Eligibility criteria expanded, about 57 words
    • Secondary endpoints: 5 to 7
    • Collaborators expanded, about 64 words
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this multicenter, randomized trial is to compare standby cannulated ECMO versus prophylactic ECMO in patients undergoing high-risk percutaneous coronary intervention (PCI). The main question it aims to answer is : • If standby cannulated ECMO as compared with prophylactic ECMO will improve the outcomes in patients undergoing high-risk PCI
Trial Details
NCT Number NCT06274411
Lead Sponsor Beijing Anzhen Hospital
Collaborators: Wuhan Asia Heart Hospital, First Affiliated Hospital of Harbin Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, People's Hospital of Guangxi Zhuang Autonomous Region, The First Affiliated Hospital of Lanzhou Medical University, Chinese Academy of Medical Sciences, Fuwai Hospital, The Second Affiliated Hospital of Harbin Medical University
Conditions
(from sponsor)		 ECMO, High-risk PCI
Enrollment 176 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov